Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
Cure8 research brief
Limited source text
What Cure8 can confirm
What We Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a systematic review or meta analysis related to Inflammatory bowel disease and Research and clinical trials. Use the original source link for the full details.
What Is Not Available
The source did not provide enough reliable article text for a source-grounded Cure8 brief. Study details, results, and limitations should be checked in the original source.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
AuthorsChoi JG, Gong EJ, Bang CS +1 more
Study typeIm, journal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedSep 11, 2026, 12:00 AM
Content availableMetadata only
Cure8 could not retrieve enough reliable source text to summarize this article. This page is based on the article title, source metadata, and Cure8 topic classification.
Pharmacological treatments for moderate-to-severe ulcerative colitis: a systematic review and Bayesian network meta-analysis
Based on the title and source metadata, this appears to be a systematic review or meta analysis related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from...
Lipoprotein (a) and inflammatory bowel disease: a systematic review and meta-analysis.
The study suggests people with Crohn's disease or ulcerative colitis have higher lipoprotein(a) levels than healthy controls, which could be relevant because Lp(a) is a cardiovascular-risk biomarker and cardiovascular...
Mesenchymal Stromal/Stem Cells in Inflammatory Bowel Disease: Crosstalk with Innate and Adaptive Immunity.
MSCs are an active research area for IBD because they may reduce harmful immune activity and help heal intestinal tissue. Patients following emerging biologic and cell therapies may want to know how MSCs could fit into...